Takeda engaged in antitrust scheme to delay generic constipation drug, US jury finds

A US jury issued an important verdict against the company Takeda.

The company Takeda wanted to delay the introduction of a cheaper constipation drug.

This drug is called Amitiza and is very popular.

The company paid other companies not to sell a generic replacement.

The court found that this action was illegal and harmful.

Because of this, patients had to pay more money for medicines.

Takeda must now pay a huge financial penalty.

This case shows that competition in the market is very important.